Abstract
Primary lung cancer is an extremely rare neoplasm in young adults. We report a case of a primary lung adenocarcinoma in an 18-year-old man who presented for examination of a solitary nodule located in the right lower lobe of the lung. A right lower lobectomy was performed with an incomplete resection because of pleural dissemination (pT4N2M0 stage IIIB adenocarcinoma). Intrathoracic chemotherapy (cisplatin, 50 mg/body) was administered initially, followed by systemic chemotherapy (carboplatin + paclitaxel). A bronchopleural fistula occurred 2 months postoperatively and was successfully treated with conservative therapy, including thoracic drainage, intrathoracic fibrin glue administration, and transbronchial superglue administration. Thereafter, a total of five courses of systemic chemotherapy with minor changes in the administration regimen were performed. The patient was alive and with no evidence of recurrence at his 5-year follow-up.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237–245.
Japanese Joint Committee for Lung Cancer Registration. A Japanese lung cancer registry study at 1999. Jpn J Chest Surg 2007;21:108–120.
Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718–1723.
Seto T, Ushijima S, Yamamoto H, Ito K, Araki J, Inoue Y, et al. Thoracic Oncology Group. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial. Br J Cancer 2006;95:717–721.
Sugaya M, Sugio K, Nagashima A, Nakanishi R, Sakata H, Nakanishi K, et al. Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. 2005 ASCO Annual Meeting Proceedings. J Clin Oncol 23:7258.
Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007;132:185–192.
Sirbu H, Busch T, Aleksic I, Schreiner W, Oster O, Dalichau H. Bronchopleural fistula in the surgery of non-small cell lung cancer: incidence, risk factors, and management. Ann Thorac Cardiovasc Surg 2001;7:330–336.
Kirsh MM, Rotman H, Behrendt DM, Orringer MB, Sloan H. Complications of pulmonary resection. Ann Thorac Surg 1975;20:215–236
Oyama T, Fujimoto H, Suito T, Takahashi Y, Fukutomi T, Naruke M. Successful conservative therapy for bronchopleural fistula after primary lung cancer resection. Jpn J Chest Surg 2010;24:18–23.
The Japan Lung Cancer Society. Evidence-based guidelines for treatment of lung cancer in Japan: 2005 edition. Tokyo: Japan Lung Cancer Society; 2005.
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958–967.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
So, T., Uramoto, H., Hanagiri, T. et al. Successful treatment of lung adenocarcinoma in an 18-year-old man. Gen Thorac Cardiovasc Surg 59, 616–618 (2011). https://doi.org/10.1007/s11748-010-0730-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-010-0730-8